DK1235573T3 - Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders - Google Patents

Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders

Info

Publication number
DK1235573T3
DK1235573T3 DK00985315T DK00985315T DK1235573T3 DK 1235573 T3 DK1235573 T3 DK 1235573T3 DK 00985315 T DK00985315 T DK 00985315T DK 00985315 T DK00985315 T DK 00985315T DK 1235573 T3 DK1235573 T3 DK 1235573T3
Authority
DK
Denmark
Prior art keywords
riluzole
gabapentin
combination
motor neuron
drug
Prior art date
Application number
DK00985315T
Other languages
Danish (da)
Inventor
Andrees Bohme
Christopher Henderson
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1235573T3 publication Critical patent/DK1235573T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention concerns the combination of riluzole and gabapentin or one of their pharmaceutically acceptable salts and its use as medicine in particular for use in preventing and /or treating motor neuron disorders.
DK00985315T 1999-11-24 2000-11-24 Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders DK1235573T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914765A FR2801217B1 (en) 1999-11-24 1999-11-24 COMBINATION OF RILUZOLE AND GABAPENTINE AND ITS USE AS A MEDICINAL PRODUCT
PCT/FR2000/003272 WO2001037832A2 (en) 1999-11-24 2000-11-24 Combination of riluzole and gabapentin and use thereof as medicine

Publications (1)

Publication Number Publication Date
DK1235573T3 true DK1235573T3 (en) 2003-11-24

Family

ID=9552471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985315T DK1235573T3 (en) 1999-11-24 2000-11-24 Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders

Country Status (10)

Country Link
EP (1) EP1235573B1 (en)
JP (1) JP4928697B2 (en)
AT (1) ATE245421T1 (en)
AU (1) AU2177401A (en)
DE (1) DE60004093T2 (en)
DK (1) DK1235573T3 (en)
ES (1) ES2198369T3 (en)
FR (1) FR2801217B1 (en)
PT (1) PT1235573E (en)
WO (1) WO2001037832A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100742001B1 (en) * 2003-03-21 2007-07-23 다이노젠 파마세우티컬스, 인코포레이티드 Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
US20060264509A1 (en) * 2003-03-21 2006-11-23 Fraser Matthew O Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
JP6340366B2 (en) * 2012-07-31 2018-06-06 イェダ リサーチ アンド デベロップメント カンパニー リミテッド Methods for diagnosing and treating motor neuron disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
FR2688138B1 (en) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN A MEDICINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS.
FR2702148B1 (en) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application of anti-convulsants in the treatment of neuro-AIDS.
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage

Also Published As

Publication number Publication date
EP1235573B1 (en) 2003-07-23
FR2801217B1 (en) 2002-12-06
ATE245421T1 (en) 2003-08-15
DE60004093D1 (en) 2003-08-28
FR2801217A1 (en) 2001-05-25
DE60004093T2 (en) 2004-06-03
ES2198369T3 (en) 2004-02-01
WO2001037832A3 (en) 2002-03-21
JP2003514858A (en) 2003-04-22
PT1235573E (en) 2003-11-28
WO2001037832A2 (en) 2001-05-31
AU2177401A (en) 2001-06-04
EP1235573A2 (en) 2002-09-04
JP4928697B2 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
CY1106733T1 (en) TREATMENT OF NEUROLOGICAL DYSFUNCTION INCLUDING SULFAMIC FRUCTOPYRANOSES AND ERYTHROPOIETIN
AR021535A1 (en) DOSAGE FORMS OF CONTROLLED RELEASE THAT INCLUDE ZOLPIDEM OR SALTS OF THE SAME
EE200300212A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic diseases
EA200100572A1 (en) METHOD OF APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR AND ONE OR MULTIPLE ANTITUMOR MEDICINES AS A COMBINED METHOD OF MEDICAL EXPOSURE IN THE TREATMENT OF NEOPLASIA
ATE551996T1 (en) TREATING OR PREVENTING DIABETES WITH CANNABIDIOL
ATE472325T1 (en) INTRACORPORAL MEDICATIONS FOR THE PHOTODYNAMIC TREATMENT OF DISEASES
ATE457166T1 (en) ORAL COMPOSITIONS FOR TREATING DIABETES
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
BRPI0407662B8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
NO307687B1 (en) Use of riluzole in the manufacture of medications for the treatment of neuro-AIDS
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
CY1106155T1 (en) USE OF 3-BENZOPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF AMPHIBLISTROID DISORDERS
BRPI0408491A (en) treatment of alzheimer's disease
PT1150704E (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
ES2177024T3 (en) EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
DK1235573T3 (en) Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders
YU39598A (en) The use of dulloxetine and its pharmaceutical composition
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
NO20012777L (en) Use of riluzole in the treatment of acoustic trauma
MXPA04001268A (en) Carbonic anhydrase inhibitor.
NO20042586L (en) Treatment Progress Mate
NO20044519L (en) Hyperforin derivatives, their use and formulations containing them
HUP0300876A2 (en) Use of diclofenac for the manufacture of medicament for the topical treatment of burns
FI20010233A0 (en) A method for treating heart failure
FR2807944B1 (en) USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY